Idexx Laboratories traded at $639.60 this Monday February 2nd, decreasing $30.86 or 4.60 percent since the previous trading session. Looking back, over the last four weeks, Idexx Laboratories lost 6.25 percent. Over the last 12 months, its price rose by 36.36 percent. Looking ahead, we forecast Idexx Laboratories to be priced at 649.81 by the end of this quarter and at 591.60 in one year, according to Trading Economics global macro models projections and analysts expectations.
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also sells a line of portable electrolytes and blood gas analyzers used in the human diagnostics market. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.